Renaissance Technologies - PLURISTEM THERAPEUTICS INC ownership

PLURISTEM THERAPEUTICS INC's ticker is PSTI and the CUSIP is 72940R300. A total of 51 filers reported holding PLURISTEM THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.43 and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of PLURISTEM THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$132,000
-15.9%
107,300
+41.7%
0.00%
Q1 2022$157,000
-54.1%
75,700
-67.7%
0.00%
Q4 2021$342,000
-66.7%
234,238
-39.5%
0.00%
-100.0%
Q3 2021$1,026,000
-36.2%
387,250
-4.6%
0.00%
-50.0%
Q2 2021$1,607,000
+1.9%
405,719
+22.7%
0.00%0.0%
Q1 2021$1,577,000
+98.1%
330,700
+337.3%
0.00%
+100.0%
Q3 2020$796,000
-13.1%
75,631
-69.7%
0.00%0.0%
Q1 2020$916,000
-14.9%
249,531
-8.7%
0.00%0.0%
Q4 2019$1,077,000
+54.5%
273,419
+46.8%
0.00%0.0%
Q3 2019$697,000186,2310.00%
Other shareholders
PLURISTEM THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
NIA IMPACT ADVISORS, LLC 732,135$1,940,0000.83%
Green Alpha Advisors, LLC 61,759$164,0000.11%
Values First Advisors, Inc. 49,179$130,0000.08%
GSA CAPITAL PARTNERS LLP 257,684$683,0000.07%
SHELTON CAPITAL MANAGEMENT 240,000$636,0000.02%
Walleye Capital LLC 154,997$411,0000.01%
PDT Partners, LLC 59,400$157,0000.01%
Archford Capital Strategies, LLC 13,091$35,0000.01%
Susquehanna International Group Ltd. 13,164$35,0000.01%
MEITAV INVESTMENT HOUSE LTD 167,593$444,0000.01%
View complete list of PLURISTEM THERAPEUTICS INC shareholders